Haemonetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.

CEO

Christopher A. Simon

CEOChristopher A. Simon

Employees

3,023

Employees3,023

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1971

Founded1971

Employees

3,023

Employees3,023

HAE Key Statistics

Market cap

3.36B

Market cap3.36B

Price-Earnings ratio

21.17

Price-Earnings ratio21.17

Dividend yield

—

Dividend yield—

Average volume

493.44K

Average volume493.44K

High today

$70.80

High today$70.80

Low today

$69.74

Low today$69.74

Open price

$69.84

Open price$69.84

Volume

467.32K

Volume467.32K

52 Week high

$94.99

52 Week high$94.99

52 Week low

$55.30

52 Week low$55.30

HAE News

Simply Wall St 7d

Market Participants Recognise Haemonetics Corporation's Earnings

Haemonetics Corporation's ( ) price-to-earnings (or "P/E") ratio of 20.5x might make it look like a sell right now compared to the market in the United States,...

Analyst ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.